Axonal Regeneration, Growth Cone, and the FIGN Gene Family: A Comprehensive Review

Area of Science:

• Neuroscience
• Cell Biology
• Molecular Biology

Background:

• Mature mammalian central nervous system (CNS) neurons have limited regenerative capacity after injury, leading to permanent deficits.
• Axonal regeneration relies on growth cone function, which is critically dependent on microtubule (MT) stability and dynamics.
• The FIGN gene family encodes microtubule-severing enzymes (MSEs) that regulate MT remodeling and axonal growth.

Purpose of the Study:

• To elucidate the regulatory mechanisms and functional roles of the FIGN gene family in neural regeneration.
• To explore FIGN family proteins as potential therapeutic targets for CNS injury and neurodegenerative diseases.

Main Methods:

• Investigated the roles of FIGN, FIGNL1, and FIGNL2 in MT dynamics and axonal regeneration.
• Utilized siRNA-mediated knockdown to inhibit FIGN and FIGNL2.
• Examined the impact of FIGN family proteins on MT integrity, growth cone dynamics, and functional recovery in preclinical models.
• Analyzed the intersection of FIGN proteins with key signaling pathways like RhoA/ROCK and PI3K/Akt.

Main Results:

• FIGN and FIGNL2 act as negative regulators of CNS regeneration by destabilizing MTs and causing growth cone collapse.
• Inhibition of FIGN or FIGNL2 via siRNA enhances MT integrity, promotes axonal regrowth, and improves functional recovery.
• FIGNL1 plays a context-dependent role, primarily in developmental neurite outgrowth.
• FIGN family proteins link cytoskeletal regulation to regenerative signaling pathways.

Conclusions:

• Targeting FIGN or FIGNL2 presents a promising neuropharmacological strategy to overcome intrinsic barriers to CNS repair.
• Modulating FIGN family proteins offers potential therapeutic avenues for treating CNS injuries like spinal cord injury and stroke, as well as neurodegenerative diseases.